An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...

“Current treatment regimens for TB are lengthy, expensive and leave patients vulnerable to relapse and lung scarring ... in clinical trials to treat cancer by accelerating programmed cell ...

An experimental drug now in clinical trials as a cancer treatment could help boost ... and less onerous therapies that reduce lung damage in TB survivors. It could also prevent lung dysfunction ...